Filtros : "Illes, Peter" Limpar

Filtros



Refine with date range


  • Source: Purinergic Signalling. Unidade: IQ

    Assunto: CIENTISTAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FALZONI, Simonetta et al. In tribute to Francesco Di Virgilio, a great scientist and a wonderful friend. Purinergic Signalling, v. 22, n. 20, p. 1-9, 2026Tradução . . Disponível em: https://dx.doi.org/10.1007/s11302-026-10135-9. Acesso em: 04 maio 2026.
    • APA

      Falzoni, S., Giuliani, A. L., Adinolfi, E., Silva, R. C., Illes, P., Robson, S. C., et al. (2026). In tribute to Francesco Di Virgilio, a great scientist and a wonderful friend. Purinergic Signalling, 22( 20), 1-9. doi:10.1007/s11302-026-10135-9
    • NLM

      Falzoni S, Giuliani AL, Adinolfi E, Silva RC, Illes P, Robson SC, Tang Y, Ulrich H, Kennedy C. In tribute to Francesco Di Virgilio, a great scientist and a wonderful friend [Internet]. Purinergic Signalling. 2026 ; 22( 20): 1-9.[citado 2026 maio 04 ] Available from: https://dx.doi.org/10.1007/s11302-026-10135-9
    • Vancouver

      Falzoni S, Giuliani AL, Adinolfi E, Silva RC, Illes P, Robson SC, Tang Y, Ulrich H, Kennedy C. In tribute to Francesco Di Virgilio, a great scientist and a wonderful friend [Internet]. Purinergic Signalling. 2026 ; 22( 20): 1-9.[citado 2026 maio 04 ] Available from: https://dx.doi.org/10.1007/s11302-026-10135-9
  • Source: MedComm. Unidade: IQ

    Subjects: RECEPTORES, ADENOSINA, TRANSTORNOS COGNITIVOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ILLES, Peter et al. Dysregulation of astrocytic ATP/adenosine release in the hippocampus cause cognitive and affective disorders: molecular mechanisms, diagnosis, and therapy. MedComm, v. 6, p. 1-23 art. e70177, 2025Tradução . . Disponível em: https://dx.doi.org/10.1002/mco2.70177. Acesso em: 04 maio 2026.
    • APA

      Illes, P., Rubini, P., Ulrich, H., Yin, H. -Y., & Tang, Y. (2025). Dysregulation of astrocytic ATP/adenosine release in the hippocampus cause cognitive and affective disorders: molecular mechanisms, diagnosis, and therapy. MedComm, 6, 1-23 art. e70177. doi:10.1002/mco2.70177
    • NLM

      Illes P, Rubini P, Ulrich H, Yin H-Y, Tang Y. Dysregulation of astrocytic ATP/adenosine release in the hippocampus cause cognitive and affective disorders: molecular mechanisms, diagnosis, and therapy [Internet]. MedComm. 2025 ; 6 1-23 art. e70177.[citado 2026 maio 04 ] Available from: https://dx.doi.org/10.1002/mco2.70177
    • Vancouver

      Illes P, Rubini P, Ulrich H, Yin H-Y, Tang Y. Dysregulation of astrocytic ATP/adenosine release in the hippocampus cause cognitive and affective disorders: molecular mechanisms, diagnosis, and therapy [Internet]. MedComm. 2025 ; 6 1-23 art. e70177.[citado 2026 maio 04 ] Available from: https://dx.doi.org/10.1002/mco2.70177
  • Source: Purinergic Signalling. Unidades: ICB, IQ

    Subjects: NEUROTRANSMISSORES, RECEPTORES, SISTEMA NERVOSO PERIFÉRICO, DOENÇAS CEREBRAIS, SINAPSE, PROTEÍNAS DA MEMBRANA, CÓRTEX CEREBRAL, HIPOCAMPO, GABA, CÉREBRO, ASTRÓCITOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      JUVENAL, Guilherme Araújo et al. Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease. Purinergic Signalling, v. 21, p. 149-177, 2025Tradução . . Disponível em: https://dx.doi.org/10.1007/s11302-024-10034-x. Acesso em: 04 maio 2026.
    • APA

      Juvenal, G. A., Higa, G. S. V., Marques, L. B., Zampieri, T. T., Viana, F. J. C., Britto, L. R. G. de, et al. (2025). Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease. Purinergic Signalling, 21, 149-177. doi:10.1007/s11302-024-10034-x
    • NLM

      Juvenal GA, Higa GSV, Marques LB, Zampieri TT, Viana FJC, Britto LRG de, Tang Y, Illes P, Virgilio FD, Ulrich H, De Pasquale R. Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease [Internet]. Purinergic Signalling. 2025 ;21 149-177.[citado 2026 maio 04 ] Available from: https://dx.doi.org/10.1007/s11302-024-10034-x
    • Vancouver

      Juvenal GA, Higa GSV, Marques LB, Zampieri TT, Viana FJC, Britto LRG de, Tang Y, Illes P, Virgilio FD, Ulrich H, De Pasquale R. Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease [Internet]. Purinergic Signalling. 2025 ;21 149-177.[citado 2026 maio 04 ] Available from: https://dx.doi.org/10.1007/s11302-024-10034-x
  • Source: Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Unidade: IQ

    Subjects: NEURÔNIOS, SISTEMA NERVOSO CENTRAL

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CAETANO, Roberta Andrejew et al. Purinergic signaling in neurogenesisand neural fate determination: current knowledge and future challenges. Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Tradução . Cham: Springer, 2023. . . Acesso em: 04 maio 2026.
    • APA

      Caetano, R. A., Turrini, N., Ye, Q., Tang, Y., Illes, P., & Ulrich, H. (2023). Purinergic signaling in neurogenesisand neural fate determination: current knowledge and future challenges. In Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Cham: Springer.
    • NLM

      Caetano RA, Turrini N, Ye Q, Tang Y, Illes P, Ulrich H. Purinergic signaling in neurogenesisand neural fate determination: current knowledge and future challenges. In: Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Cham: Springer; 2023. [citado 2026 maio 04 ]
    • Vancouver

      Caetano RA, Turrini N, Ye Q, Tang Y, Illes P, Ulrich H. Purinergic signaling in neurogenesisand neural fate determination: current knowledge and future challenges. In: Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Cham: Springer; 2023. [citado 2026 maio 04 ]
  • Unidade: IQ

    Subjects: RECEPTORES, NUCLEOTÍDEOS

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ULRICH, Henning e ILLES, Peter e GLASER, Talita. Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration. . Cham: Springer. . Acesso em: 04 maio 2026. , 2023
    • APA

      Ulrich, H., Illes, P., & Glaser, T. (2023). Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration. Cham: Springer.
    • NLM

      Ulrich H, Illes P, Glaser T. Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration. 2023 ;[citado 2026 maio 04 ]
    • Vancouver

      Ulrich H, Illes P, Glaser T. Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration. 2023 ;[citado 2026 maio 04 ]
  • Source: Neurobiology of Disease. Unidade: IQ

    Subjects: TRANSTORNOS MENTAIS, DOENÇAS NEURODEGENERATIVAS, RECEPTORES

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ILLES, Peter et al. Purinergic receptors in cognitive disturbances. Neurobiology of Disease, v. 185, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.nbd.2023.106229. Acesso em: 04 maio 2026.
    • APA

      Illes, P., Ulrich, H., Chen, J. F., & Tang, Y. (2023). Purinergic receptors in cognitive disturbances. Neurobiology of Disease, 185, 1-16. doi:10.1016/j.nbd.2023.106229
    • NLM

      Illes P, Ulrich H, Chen JF, Tang Y. Purinergic receptors in cognitive disturbances [Internet]. Neurobiology of Disease. 2023 ; 185 1-16.[citado 2026 maio 04 ] Available from: https://doi.org/10.1016/j.nbd.2023.106229
    • Vancouver

      Illes P, Ulrich H, Chen JF, Tang Y. Purinergic receptors in cognitive disturbances [Internet]. Neurobiology of Disease. 2023 ; 185 1-16.[citado 2026 maio 04 ] Available from: https://doi.org/10.1016/j.nbd.2023.106229
  • Source: Frontiers in Pharmacology. Unidade: IQ

    Subjects: PURINAS, RECEPTORES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CIRUELA, Francisco et al. Purinergic Signaling 2020: the state-of-the-art commented by the members of the Italian Purine Club [Editorial]. Frontiers in Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fphar.2021.768923. Acesso em: 04 maio 2026. , 2021
    • APA

      Ciruela, F., Fuxe, K., Illes, P., Ulrich, H., & Caciagli, F. (2021). Purinergic Signaling 2020: the state-of-the-art commented by the members of the Italian Purine Club [Editorial]. Frontiers in Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. doi:10.3389/fphar.2021.768923
    • NLM

      Ciruela F, Fuxe K, Illes P, Ulrich H, Caciagli F. Purinergic Signaling 2020: the state-of-the-art commented by the members of the Italian Purine Club [Editorial] [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-3.[citado 2026 maio 04 ] Available from: https://doi.org/10.3389/fphar.2021.768923
    • Vancouver

      Ciruela F, Fuxe K, Illes P, Ulrich H, Caciagli F. Purinergic Signaling 2020: the state-of-the-art commented by the members of the Italian Purine Club [Editorial] [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-3.[citado 2026 maio 04 ] Available from: https://doi.org/10.3389/fphar.2021.768923
  • Source: Signal Transduction and Targeted Therapy. Unidade: IQ

    Subjects: PURINAS, DOENÇAS NEURODEGENERATIVAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HUANG, Zhao et al. From purines to purinergic signalling: molecular functions and human diseases. Signal Transduction and Targeted Therapy, v. 6, p. 1-20 art. 162, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41392-021-00553-z. Acesso em: 04 maio 2026.
    • APA

      Huang, Z., Xie, N., Illes, P., Virgilio, F. D., Ulrich, H., Semyanov, A., et al. (2021). From purines to purinergic signalling: molecular functions and human diseases. Signal Transduction and Targeted Therapy, 6, 1-20 art. 162. doi:10.1038/s41392-021-00553-z
    • NLM

      Huang Z, Xie N, Illes P, Virgilio FD, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu S-G, Huang C, Tang Y. From purines to purinergic signalling: molecular functions and human diseases [Internet]. Signal Transduction and Targeted Therapy. 2021 ; 6 1-20 art. 162.[citado 2026 maio 04 ] Available from: https://doi.org/10.1038/s41392-021-00553-z
    • Vancouver

      Huang Z, Xie N, Illes P, Virgilio FD, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu S-G, Huang C, Tang Y. From purines to purinergic signalling: molecular functions and human diseases [Internet]. Signal Transduction and Targeted Therapy. 2021 ; 6 1-20 art. 162.[citado 2026 maio 04 ] Available from: https://doi.org/10.1038/s41392-021-00553-z
  • Source: Purinergic Signalling. Unidade: IQ

    Subjects: RECEPTORES, ADENOSINA TRIFOSFATO, FARMACOLOGIA, BIOQUÍMICA, BIOLOGIA MOLECULAR

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      WANG, Tao et al. Optical control of purinergic signaling. Purinergic Signalling, v. 17, p. 385–392, 2021Tradução . . Disponível em: https://doi.org/10.1007/s11302-021-09799-2. Acesso em: 04 maio 2026.
    • APA

      Wang, T., Ulrich, H., Semyanov, A., Illes, P., & Tang, Y. (2021). Optical control of purinergic signaling. Purinergic Signalling, 17, 385–392. doi:10.1007/s11302-021-09799-2
    • NLM

      Wang T, Ulrich H, Semyanov A, Illes P, Tang Y. Optical control of purinergic signaling [Internet]. Purinergic Signalling. 2021 ; 17 385–392.[citado 2026 maio 04 ] Available from: https://doi.org/10.1007/s11302-021-09799-2
    • Vancouver

      Wang T, Ulrich H, Semyanov A, Illes P, Tang Y. Optical control of purinergic signaling [Internet]. Purinergic Signalling. 2021 ; 17 385–392.[citado 2026 maio 04 ] Available from: https://doi.org/10.1007/s11302-021-09799-2
  • Source: Neuroscience Bulletin. Unidade: IQ

    Subjects: ANALGÉSICOS, DOR

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      REN, Wen-Jing et al. TASK-3: new target for pain-relief. Neuroscience Bulletin, v. 36, n. 8, p. 951–954, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12264-020-00516-4. Acesso em: 04 maio 2026.
    • APA

      Ren, W. -J., Ulrich, H., Semyanov, A., Illes, P., & Tang, Y. (2020). TASK-3: new target for pain-relief. Neuroscience Bulletin, 36( 8), 951–954. doi:10.1007/s12264-020-00516-4
    • NLM

      Ren W-J, Ulrich H, Semyanov A, Illes P, Tang Y. TASK-3: new target for pain-relief [Internet]. Neuroscience Bulletin. 2020 ; 36( 8): 951–954.[citado 2026 maio 04 ] Available from: https://doi.org/10.1007/s12264-020-00516-4
    • Vancouver

      Ren W-J, Ulrich H, Semyanov A, Illes P, Tang Y. TASK-3: new target for pain-relief [Internet]. Neuroscience Bulletin. 2020 ; 36( 8): 951–954.[citado 2026 maio 04 ] Available from: https://doi.org/10.1007/s12264-020-00516-4
  • Source: Neuroscience Bulletin. Unidade: IQ

    Subjects: RECEPTORES, DOENÇA DE PARKINSON, DOENÇAS DOS GÂNGLIOS DE BASE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GLASER, Talita et al. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease. Neuroscience Bulletin, v. 36, n. 11, p. 1299–1314, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12264-020-00582-8. Acesso em: 04 maio 2026.
    • APA

      Glaser, T., Andrejew, R., Giacomelli, Á. O., Ribeiro, D. E., Marques, L. B., Ye, Q., et al. (2020). Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease. Neuroscience Bulletin, 36( 11), 1299–1314. doi:10.1007/s12264-020-00582-8
    • NLM

      Glaser T, Andrejew R, Giacomelli ÁO, Ribeiro DE, Marques LB, Ye Q, Ren W-J, Semyanov A, Illes P, Tang Y, Ulrich H. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease [Internet]. Neuroscience Bulletin. 2020 ; 36( 11): 1299–1314.[citado 2026 maio 04 ] Available from: https://doi.org/10.1007/s12264-020-00582-8
    • Vancouver

      Glaser T, Andrejew R, Giacomelli ÁO, Ribeiro DE, Marques LB, Ye Q, Ren W-J, Semyanov A, Illes P, Tang Y, Ulrich H. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease [Internet]. Neuroscience Bulletin. 2020 ; 36( 11): 1299–1314.[citado 2026 maio 04 ] Available from: https://doi.org/10.1007/s12264-020-00582-8
  • Source: Neural Regeneration Research. Unidade: IQ

    Subjects: DIFERENCIAÇÃO CELULAR, RECEPTORES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ULRICH, Henning e ILLES, Peter. P2X receptors in maintenance and differentiation of neural progenitor cells. Neural Regeneration Research, v. 9, n. 23, p. 2040-2041, 2014Tradução . . Disponível em: https://doi.org/10.4103/1673-5374.147925. Acesso em: 04 maio 2026.
    • APA

      Ulrich, H., & Illes, P. (2014). P2X receptors in maintenance and differentiation of neural progenitor cells. Neural Regeneration Research, 9( 23), 2040-2041. doi:10.4103/1673-5374.147925
    • NLM

      Ulrich H, Illes P. P2X receptors in maintenance and differentiation of neural progenitor cells [Internet]. Neural Regeneration Research. 2014 ; 9( 23): 2040-2041.[citado 2026 maio 04 ] Available from: https://doi.org/10.4103/1673-5374.147925
    • Vancouver

      Ulrich H, Illes P. P2X receptors in maintenance and differentiation of neural progenitor cells [Internet]. Neural Regeneration Research. 2014 ; 9( 23): 2040-2041.[citado 2026 maio 04 ] Available from: https://doi.org/10.4103/1673-5374.147925

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2026